Gilead Sciences
Utility Patents
Last updated:
List of all Gilead Sciences patents 121 in total
| Status | Patent |
|---|---|
Grant | Utility: Substituted pyrrolizine compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Methods and compounds for treating Paramyxoviridae virus infections Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Solid forms of a toll-like receptor modulator Filling date: 6 Sep 2025 Issue date: 26 Jul 2022 |
Grant | Utility: Methods for treating Arenaviridae and Coronaviridae virus infections Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Thienopyrimidine derivatives as ACC inhibitors and uses thereof Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: HIV protease inhibitors Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Methods for the preparation of ribosides Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Combination formulation of three antiviral compounds Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Cot modulators and methods of use thereof Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Processes and intermediates for preparing MCL1 inhibitors Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: HIV protease inhibitors Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Quinazoline compounds Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Processes for preparing toll-like receptor modulator compounds Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Processes for preparing ACC inhibitors and solid forms thereof Filling date: 6 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Therapeutic compounds Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Choline salt forms of an HIV capsid inhibitor Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods for treating Filoviridae virus infections Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Solid forms of an HIV capsid inhibitor Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods of treating feline coronavirus infections Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Processes for preparing ASK1 inhibitors Filling date: 6 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Metabolites of bictegravir Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: PD-1/PD-L1 inhibitors Filling date: 6 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: FXR (NR1H4) modulating compounds Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Compounds for inhibition of alpha 4 beta 7 integrin Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Substituted pyrido[1,2-a]pyrrolo[1,2-d]pyrazines for treating viral infections Filling date: 6 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13- ,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-1- 0-carboxamide Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Substituted 6-azabenzimidazole compounds Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Compounds for inhibition of .alpha.4.beta.7 integrin Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Imidazopyrimidine derivatives Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Imidazopyridine derivatives Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Antibodies that target HIV GP120 and methods of use Filling date: 6 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: FLT3L-FC fusion proteins Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Toll like receptor modulator compounds Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Methods and intermediates for preparing therapeutic compounds Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Quinoline derivatives Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Modulators of toll-like receptors for the treatment of HIV Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Modulators of toll-like receptors Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Apoptosis signal-regulating kinase inhibitors Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Therapeutic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: HIV inhibitor compounds Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Solid forms of a toll-like receptor modulator Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Substituted 6-azabenzimidazole compounds Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Cot modulators and methods of use thereof Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Pyrrolo[1,2-b]pyridazine derivatives Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Anti-HIV compounds Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Showing 1 to 50 of 121 patents.